199 related articles for article (PubMed ID: 10929075)
1. gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy.
Martini F; Urso R; Gioia C; De Felici A; Narciso P; Amendola A; Paglia MG; Colizzi V; Poccia F
Immunology; 2000 Aug; 100(4):481-6. PubMed ID: 10929075
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
Negash M; Tsegaye A; Wassie L; Howe R
BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
[TBL] [Abstract][Full Text] [Related]
3. Bacterial antigen activation of Vdelta1 and Vdelta2 gammadelta T cells of persons infected with human immunodeficiency virus type 1.
Chervenak KA; Lederman MM; Boom WH
J Infect Dis; 1997 Feb; 175(2):429-33. PubMed ID: 9203665
[TBL] [Abstract][Full Text] [Related]
4. Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons.
Poccia F; Boullier S; Lecoeur H; Cochet M; Poquet Y; Colizzi V; Fournie JJ; Gougeon ML
J Immunol; 1996 Jul; 157(1):449-61. PubMed ID: 8683151
[TBL] [Abstract][Full Text] [Related]
5. Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.
Kosub DA; Lehrman G; Milush JM; Zhou D; Chacko E; Leone A; Gordon S; Silvestri G; Else JG; Keiser P; Jain MK; Sodora DL
J Virol; 2008 Feb; 82(3):1155-65. PubMed ID: 18045946
[TBL] [Abstract][Full Text] [Related]
6. Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation.
Poggi A; Catellani S; Musso A; Zocchi MR
Curr Med Chem; 2009; 16(35):4743-9. PubMed ID: 19903136
[TBL] [Abstract][Full Text] [Related]
7. gammadelta T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection.
Carvalho AC; Matteelli A; Airò P; Tedoldi S; Casalini C; Imberti L; Cadeo GP; Beltrame A; Carosi G
Thorax; 2002 Apr; 57(4):357-60. PubMed ID: 11923557
[TBL] [Abstract][Full Text] [Related]
8. Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy.
Agrati C; D'Offizi G; Narciso P; Selva C; Pucillo LP; Ippolito G; Poccia F
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1357-63. PubMed ID: 11602046
[TBL] [Abstract][Full Text] [Related]
9. Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages.
De Rosa SC; Mitra DK; Watanabe N; Herzenberg LA; Herzenberg LA; Roederer M
J Leukoc Biol; 2001 Oct; 70(4):518-26. PubMed ID: 11590187
[TBL] [Abstract][Full Text] [Related]
10. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons.
Boullier S; Poquet Y; Debord T; Fournie JJ; Gougeon ML
Eur J Immunol; 1999 Jan; 29(1):90-9. PubMed ID: 9933090
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
[TBL] [Abstract][Full Text] [Related]
12. Immune regulation of gammadelta T cell responses in mycobacterial infections.
Chen ZW
Clin Immunol; 2005 Sep; 116(3):202-7. PubMed ID: 16087145
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity and anergy of gammadeltaT lymphocytes in cord blood and immuno-compromised host.
Montesano C; Gioia C; Martini F; Agrati C; Cairo C; Pucillo LP; Colizzi V; Poccia F
J Biol Regul Homeost Agents; 2001; 15(3):257-64. PubMed ID: 11693434
[TBL] [Abstract][Full Text] [Related]
14. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
15. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
[TBL] [Abstract][Full Text] [Related]
16. γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activation.
Chevalier MF; Bhatnagar N; Didier C; Lopez-Gonzalez M; Pavie J; Bollens D; Duvivier C; Collias L; Jung C; Scott-Algara D; Girard PM; Weiss L;
AIDS; 2019 Jul; 33(8):1283-1292. PubMed ID: 30870199
[TBL] [Abstract][Full Text] [Related]
17. In Human Immunodeficiency Virus primary infection, early combined antiretroviral therapy reduced γδ T-cell activation but failed to restore their polyfunctionality.
Casetti R; Sacchi A; Bordoni V; Grassi G; Cimini E; Besi F; Pinnetti C; Mondi A; Antinori A; Agrati C
Immunology; 2019 Aug; 157(4):322-330. PubMed ID: 31206171
[TBL] [Abstract][Full Text] [Related]
18. Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans.
Fenoglio D; Poggi A; Catellani S; Battaglia F; Ferrera A; Setti M; Murdaca G; Zocchi MR
Blood; 2009 Jun; 113(26):6611-8. PubMed ID: 19395673
[TBL] [Abstract][Full Text] [Related]
19. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
Maeurer MJ; Martin D; Walter W; Liu K; Zitvogel L; Halusczcak K; Rabinowich H; Duquesnoy R; Storkus W; Lotze MT
J Exp Med; 1996 Apr; 183(4):1681-96. PubMed ID: 8666926
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
